Neuronetics, Inc.
STIM
$1.94
$0.2414.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 85.73% | 101.28% | 131.66% | 83.59% | 10.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.73% | 101.28% | 131.66% | 83.59% | 10.73% |
| Cost of Revenue | 181.04% | 345.77% | 376.47% | 275.08% | 164.85% |
| Gross Profit | 42.67% | 22.19% | 45.81% | 20.25% | -12.33% |
| SG&A Expenses | 21.79% | 18.70% | 30.17% | 42.83% | 14.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.13% | 69.92% | 84.98% | 77.08% | 46.08% |
| Operating Income | 57.29% | 5.27% | 5.28% | -60.58% | -330.23% |
| Income Before Tax | 43.17% | 29.53% | -0.07% | -61.17% | -135.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.17% | 29.53% | -0.07% | -61.17% | -135.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 152.63% | -- | -- | -- | -- |
| Net Income | 43.47% | 32.20% | -2.93% | -60.99% | -135.48% |
| EBIT | 57.29% | 5.27% | 5.28% | -60.58% | -330.23% |
| EBITDA | 62.57% | 10.82% | 10.00% | -60.39% | -397.45% |
| EPS Basic | 69.85% | 69.51% | 53.27% | 22.80% | -86.55% |
| Normalized Basic EPS | 70.20% | 55.46% | 52.47% | 22.87% | -174.60% |
| EPS Diluted | 69.85% | 69.51% | 53.27% | 22.80% | -86.55% |
| Normalized Diluted EPS | 70.20% | 55.46% | 52.47% | 22.87% | -174.60% |
| Average Basic Shares Outstanding | 87.48% | 122.38% | 120.22% | 108.55% | 26.25% |
| Average Diluted Shares Outstanding | 87.48% | 122.38% | 120.22% | 108.55% | 26.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |